We at CFIF often highlight the clear and present danger that drug price control schemes pose to American…
CFIF on Twitter CFIF on YouTube
New Lung Cancer Breakthrough Illustrates the Potential Peril of Drug Price Controls

We at CFIF often highlight the clear and present danger that drug price control schemes pose to American consumers, who benefit from our private pharmaceutical sector that leads the world - by far - in innovation.  A new lung cancer treatment breakthrough in the form of Amgen's Lumakras illustrates that interrelationship.

Simply put, Lumakras reduced the risk of progression by 34% compared to chemotherapy in patents with advanced lung cancer, which is particularly welcome considering lung cancer's especially low survival rate (18.6% over five years, and just 5% for advanced forms).  The breakthrough required years of research and enormous amounts of investment, however, which The Wall Street Journal notes makes Lumakras the type of innovation put at risk by new drug price controls…[more]

September 22, 2022 • 05:06 PM

Liberty Update

CFIFs latest news, commentary and alerts delivered to your inbox.
Jester's Courtroom Legal tales stranger than stranger than fiction: Ridiculous and sometimes funny lawsuits plaguing our courts
Home Press Room CFIF Reiterates Opposition to H.R. 3, Nancy Pelosi’s Socialized Medicine Bill
CFIF Reiterates Opposition to H.R. 3, Nancy Pelosi’s Socialized Medicine Bill Print
Thursday, April 22 2021

 ALEXANDRIA, VA – Today, Democrats in the House of Representatives doubled down on Speaker Pelosi’s plan to impose a socialized drug pricing system that would import foreign price controls, stifle innovation and limit patient access by reintroducing H.R. 3, the deceptively-titled “Lower Drug Costs Now Act.”  What follows is a statement by CFIF President Jeffrey Mazzella: 

"CFIF unambiguously reiterates its opposition to this catastrophic legislation, which amounts to the worst and most far-reaching attempt yet to impose government control over Americans’ healthcare access.  

“As CFIF has been warning for years, H.R. 3 includes such mechanisms as foreign price controls, compulsory arbitration with government bureaucrats, a complete restructuring of the popular Medicare Part D program and what amounts to a retroactive 95% tax on many of the most commonly used medicines in America.  

“As CFIF has long highlighted, America enjoys – by far – the most innovative pharmaceutical industry in the world, accounting for two-thirds of all new lifesaving and life-improving drugs globally.  But importing price controls from foreign nations – which ignore drug patents to extort compliance – would result in American consumers suffering the same drawbacks that consumers in those nations do.  Namely, limited or no access to critical life-saving and life-improving drugs.  

“As even the United Nations World Health Organization (WHO) acknowledges, price controls suffocate innovation and delay the arrival of new drugs, or deny them entirely.  It’s therefore no accident that nations imposing price controls enjoy only a fraction of the new pharmaceuticals that Americans access, and that the United States outpaces those countries in terms of cancer survival rates and other benefits.  This bill also jeopardizes tens of billions of dollars spent annually on research and development by the pharmaceutical industry.  

“All of this is far too high a price for Americans to pay for Nancy Pelosi’s socialized medicine pet project.”  

CFIF is a constitutional and free market advocacy organization with over 300,000 supporters and activists nationwide.  

###

Related Articles :
Quiz Question   
Which one of the following U.S. Presidents signed the executive order establishing the Federal Emergency Management Agency (FEMA)?
More Questions
Notable Quote   
 
"The Internal Revenue Service (IRS) sent over $1.1 billion in child tax credit payments to incorrect recipients during the COVID-19 pandemic, according to an audit by the Department of the Treasury's Inspector General (IG) for Tax Administration on Tuesday.The IRS sent the payments to 1.5 million people between July and November of 2021 during the pandemic, according to the audit. Additionally, the…[more]
 
 
—Arjun Singh, The Daily Caller News Foundation
— Arjun Singh, The Daily Caller News Foundation
 
Liberty Poll   

Choosing from the list below, what issue is currently most important to you heading into the mid-term elections?